Skip to main content
. 2000 Mar 20;191(6):937–948. doi: 10.1084/jem.191.6.937

Figure 1.

Figure 1

Flow cytometric analysis of JR.2 and XV.1 lines. The mAbs used were P3 (IgG control), SPV-T3b (anti-CD3), OKT4 (anti-CD4), OKT8 (anti-CD8α), 9.3 (anti-CD28), DX1 (anti–NKR-P1A), anti–TCR-δ1 (pan anti-Cδ TCR), δTCS1 (anti-Vδ1/Jδ1), TiγA (anti-Vγ2), and 4A11 (anti-Vγ1.4).